KURA Kura Oncology, Inc.

HealthcareBiotechnology
$9.32
▼ 2.51%
36
QScore Signal
Short
Confidence: MEDIUM
Long-Term
27
Short-Term
44

Value

17
P/E-2.94
8
P/B4.71
45
P/S12.26
13
EV/EBITDA-2.41
5

Growth

56
Revenue Growth25.2%
93
EPS Growth-57.4%
39
FCF Growth-152.8%
27

Momentum

71
12-Month Return61.0%
93
3-Month Return25.9%
100
1-Month Return6.0%
64
RSI (14)42.56
50
50/200 MABearish
30

Profitability

18
ROE-102.6%
31
ROA-37.7%
0
Gross Margin94.6%
75
Operating Margin-449.9%
0
Net Margin-412.9%
0
FCF Yield-8.5%
0

Risk

16
Beta0.32
35
60-Day Volatility44.1%
0

Generated 5/7/2026, 9:23:20 PM · How is this calculated?

QScore Analysis